AU4454389A - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number: AU4454389A
Authority: AU; Australia
Prior art keywords: pharmaceutical composition; pharmaceutical; composition
Prior art date: 1984-06-14
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU44543/89A

Inventor

Hans Peter Bier

Wolfgang Czarnecki

Jean Claude Gfeller

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sandoz AG

Original Assignee

Sandoz AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-06-14

Filing date

1989-11-09

Publication date

1990-03-22

1989-11-09 Application filed by Sandoz AG filed Critical Sandoz AG

1990-03-22 Publication of AU4454389A publication Critical patent/AU4454389A/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

AU44543/89A 1984-06-14 1989-11-09 Pharmaceutical composition Abandoned AU4454389A (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
DE3422083		1984-06-14
DE3422083		1984-06-14
DE3442566		1984-11-22
DE3442566		1984-11-22

Related Parent Applications (1)

Application Number	Title	Priority Date	Filing Date
AU43486/85A Division AU587190B2 (en)	1984-06-14	1985-06-12	Novel galenical retard form

Publications (1)

Publication Number	Publication Date
AU4454389A true AU4454389A (en)	1990-03-22

Family

ID=25822108

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AU43486/85A Ceased AU587190B2 (en)	1984-06-14	1985-06-12	Novel galenical retard form
AU44543/89A Abandoned AU4454389A (en)	1984-06-14	1989-11-09	Pharmaceutical composition

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AU43486/85A Ceased AU587190B2 (en)	1984-06-14	1985-06-12	Novel galenical retard form

Country Status (21)

Country	Link
AT (1)	AT391806B (en)
AU (2)	AU587190B2 (en)
BE (1)	BE902626A (en)
CA (1)	CA1264441A (en)
CY (1)	CY1635A (en)
DE (1)	DE3520184C2 (en)
DK (1)	DK167649B1 (en)
ES (1)	ES8702141A1 (en)
FR (1)	FR2565822B1 (en)
GB (3)	GB2160100B (en)
GR (1)	GR851430B (en)
HK (1)	HK25192A (en)
HU (1)	HU198844B (en)
IE (1)	IE58834B1 (en)
IL (1)	IL75490A0 (en)
IT (1)	IT1200080B (en)
LU (1)	LU85946A1 (en)
NL (1)	NL194389C (en)
NZ (1)	NZ212390A (en)
PT (1)	PT80635B (en)
SE (1)	SE504583C2 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1187751B (en) *	1985-10-15	1987-12-23	Eurand Spa	PROCEDURE FOR THE PREPARATION OF SOLID FORMULATIONS OF NIFEDIPINE WITH HIGH BIO AVAILABILITY AND WITH PROLONGED EFFECT AND FORMULATIONS SO OBTAINED
US4816263A (en) *	1987-10-02	1989-03-28	Alza Corporation	Dosage form for treating cardiovascular diseases comprising isradipine
WO1989009066A1 (en) *	1988-03-24	1989-10-05	Bukh Meditec A/S	Controlled release composition
GR1000270B (en) *	1988-09-30	1992-05-12	Alza Corp	Dose for cardiovascular troubles therapy
DK469989D0 (en) *	1989-09-22	1989-09-22	Bukh Meditec	PHARMACEUTICAL PREPARATION
MX9300110A (en) *	1992-01-13	1994-07-29	Gerhard Gergely	PHARMACEUTICAL PREPARATION IN THE FORM OF AN EFFERVESCENCE OR DISINTEGRATION TABLET OR OF AN INSTANT-TYPE GRANULATE AND PROCEDURE FOR ITS PREPARATION.
DE4201179A1 (en) *	1992-01-17	1993-07-22	Alfatec Pharma Gmbh	Granulates or pellets comprising dispersion of active agent in hydrophilic macromolecules - are e.g. for treatment of depression, hypertension, rheumatism, etc.
US5773025A (en) *	1993-09-09	1998-06-30	Edward Mendell Co., Inc.	Sustained release heterodisperse hydrogel systems--amorphous drugs
US6726930B1 (en)	1993-09-09	2004-04-27	Penwest Pharmaceuticals Co.	Sustained release heterodisperse hydrogel systems for insoluble drugs
US5455046A (en) *	1993-09-09	1995-10-03	Edward Mendell Co., Inc.	Sustained release heterodisperse hydrogel systems for insoluble drugs
GB2281697A (en) *	1993-09-14	1995-03-15	Euro Celtique Sa	Laxative compositions in capsules
JP3148256B2 (en)	1996-07-08	2001-03-19	エドワードメンデルカンパニー．，インコーポレーテッド	Sustained release matrix for high dose poorly soluble drugs
DE19710009A1 (en) *	1997-03-12	1998-09-24	Knoll Ag	Multi-phase preparation forms containing active ingredients
US6056977A (en)	1997-10-15	2000-05-02	Edward Mendell Co., Inc.	Once-a-day controlled release sulfonylurea formulation
US6787157B1 (en)	1998-03-10	2004-09-07	Abbott Laboratories	Multiphase active ingredient-containing formulations
US7001892B1 (en)	1999-06-11	2006-02-21	Purdue Research Foundation	Pharmaceutical materials and methods for their preparation and use
EP1189599A2 (en) *	1999-06-11	2002-03-27	Eli Lilly And Company	Pharmaceutical materials and methods for their preparation and use
WO2001010466A1 (en) *	1999-08-04	2001-02-15	Yamanouchi Pharmaceutical Co., Ltd.	Stable medicinal compositions for oral use
CA2352211C (en)	1999-09-30	2009-03-24	Edward Mendell Co., Inc.	Sustained release matrix systems for highly soluble drugs
JP2004518709A (en) *	2001-02-13	2004-06-24	アストラゼネカ・アクチエボラーグ	New modified release formulation
US7135436B2 (en)	2003-05-05	2006-11-14	J.F. Daley International, Ltd.	Solid algicide, preparation and usage in recirculating water
EP1690528A1 (en)	2005-02-11	2006-08-16	Abbott GmbH & Co. KG	Process for the preparation of dosage forms comprising a solid dispersion of a microcrystalline active agent
US20100210792A1 (en)	2006-12-05	2010-08-19	David Taft	Drug delivery
US8399007B2 (en)	2006-12-05	2013-03-19	Landec Corporation	Method for formulating a controlled-release pharmaceutical formulation
US8114883B2 (en)	2007-12-04	2012-02-14	Landec Corporation	Polymer formulations for delivery of bioactive materials
US9192578B2 (en) *	2008-08-20	2015-11-24	Board Of Regents, The University Of Texas System	Hot-melt extrusion of modified release multi-particulates

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1617362A1 (en) *	1967-11-17	1971-03-25	Beiersdorf Ag	Process for the production of medicaments with delayed release of active substances in the form of capsules
DE2400819C2 (en) *	1974-01-09	1982-04-22	Bayer Ag, 5090 Leverkusen	Process for the production of solid preparations of poorly soluble active pharmaceutical ingredients in extremely fine distribution
DE2546577B2 (en) *	1975-10-17	1981-04-02	Sandoz-Patent-GmbH, 7850 Lörrach	Solid substances made from polyvinylpyrrolidone and ergot alkaloids
GB1504553A (en) *	1975-11-17	1978-03-22	Sandoz Ltd	Tablet formulations
GB1579818A (en) *	1977-06-07	1980-11-26	Yamanouchi Pharma Co Ltd	Nifedipine-containing solid preparation composition
CH639659A5 (en) *	1978-12-18	1983-11-30	Sandoz Ag	NEW 1,4-DIHYDROPYRIDINE DERIVATIVES, THEIR PRODUCTION AND USE.
FI64938C (en) *	1977-06-20	1984-02-10	Sandoz Ag	PROCEDURE FOR THE FRAMEWORK OF THERAPEUTIC THERAPEUTIC BENSOX A- AND OX BENZOTIADIAZOLYL-1,4-DIHYDROPYRID DERIVATIVES
EP0001247A1 (en) *	1977-09-14	1979-04-04	Kanebo, Ltd.	Pharmaceutical preparation containing nifedipine and a method for producing the same.
CH642259A5 (en) *	1978-12-21	1984-04-13	Sandoz Ag	GALENIC PREPARATIONS FOR ORAL APPLICATION OF ERGOTAL CALOIDS.
DE2904310A1 (en) *	1979-02-05	1980-08-07	Boehringer Mannheim Gmbh	MOLDINGS WITH RETARDED ACTIVE SUBSTANCE RELEASE AND METHOD FOR THE PRODUCTION THEREOF
JPS56115726A (en) *	1980-02-20	1981-09-11	Kaken Pharmaceut Co Ltd	Pharmaceutical containing nifedipine
DE3033919A1 (en) *	1980-09-09	1982-04-22	Bayer Ag, 5090 Leverkusen	SOLID PHARMACEUTICAL PREPARATIONS CONTAINING NIFEDIPINE AND METHOD FOR THE PRODUCTION THEREOF
US4442112A (en) *	1981-09-02	1984-04-10	Sandoz Ltd.	Dihydropyridine derivatives useful in treating vascular headaches
DE3270785D1 (en) *	1981-10-29	1986-05-28	Bayer Ag	Process for preparing solid fast-releasing drug formulations of dihydropyridines
CA1208558A (en) *	1982-10-07	1986-07-29	Kazuo Kigasawa	Soft buccal
DE3318649A1 (en) *	1983-05-21	1984-11-22	Bayer Ag, 5090 Leverkusen	TWO-PHASE FORMULATION

1985
- 1985-05-31 NL NL8501578A patent/NL194389C/en not_active IP Right Cessation
- 1985-05-31 HU HU852126A patent/HU198844B/en unknown
- 1985-06-05 DE DE3520184A patent/DE3520184C2/en not_active Expired - Lifetime
- 1985-06-10 FR FR858508850A patent/FR2565822B1/en not_active Expired
- 1985-06-10 BE BE1/011271A patent/BE902626A/en not_active IP Right Cessation
- 1985-06-12 GB GB8514855A patent/GB2160100B/en not_active Expired
- 1985-06-12 ES ES544075A patent/ES8702141A1/en not_active Expired
- 1985-06-12 GR GR851430A patent/GR851430B/el unknown
- 1985-06-12 DK DK264785A patent/DK167649B1/en not_active IP Right Cessation
- 1985-06-12 CA CA000483768A patent/CA1264441A/en not_active Expired
- 1985-06-12 AU AU43486/85A patent/AU587190B2/en not_active Ceased
- 1985-06-12 AT AT0174885A patent/AT391806B/en not_active IP Right Cessation
- 1985-06-12 IL IL75490A patent/IL75490A0/en not_active IP Right Cessation
- 1985-06-12 NZ NZ212390A patent/NZ212390A/en unknown
- 1985-06-12 IE IE146085A patent/IE58834B1/en not_active IP Right Cessation
- 1985-06-12 PT PT80635A patent/PT80635B/en unknown
- 1985-06-13 IT IT8548210A patent/IT1200080B/en active
- 1985-06-13 LU LU85946A patent/LU85946A1/en unknown
- 1985-06-13 SE SE8502950A patent/SE504583C2/en not_active IP Right Cessation
1987
- 1987-11-19 GB GB8727055A patent/GB2196851B/en not_active Expired
- 1987-11-19 GB GB8727056A patent/GB2196852B/en not_active Expired
1989
- 1989-11-09 AU AU44543/89A patent/AU4454389A/en not_active Abandoned
1992
- 1992-04-02 HK HK251/92A patent/HK25192A/en not_active IP Right Cessation
- 1992-11-06 CY CY1635A patent/CY1635A/en unknown

Also Published As

Publication number	Publication date
GB2196851B (en)	1989-06-07
ES8702141A1 (en)	1987-01-01
NL194389C (en)	2002-03-04
CA1264441A (en)	1990-01-16
NL194389B (en)	2001-11-01
AU587190B2 (en)	1989-08-10
FR2565822A1 (en)	1985-12-20
AU4348685A (en)	1985-12-19
LU85946A1 (en)	1986-01-24
GB2160100B (en)	1989-06-01
PT80635A (en)	1985-07-01
GB2196851A (en)	1988-05-11
ATA174885A (en)	1990-06-15
PT80635B (en)	1987-10-20
CY1635A (en)	1992-11-06
IE851460L (en)	1985-12-14
HK25192A (en)	1992-04-10
SE504583C2 (en)	1997-03-10
DK264785A (en)	1985-12-15
IL75490A0 (en)	1985-10-31
GB8514855D0 (en)	1985-07-17
ES544075A0 (en)	1987-01-01
GB8727056D0 (en)	1987-12-23
NZ212390A (en)	1992-02-25
DK167649B1 (en)	1993-12-06
HU198844B (en)	1989-12-28
GB2160100A (en)	1985-12-18
DK264785D0 (en)	1985-06-12
GB2196852B (en)	1989-05-17
NL8501578A (en)	1986-01-02
SE8502950D0 (en)	1985-06-13
SE8502950L (en)	1985-12-15
DE3520184A1 (en)	1985-12-19
BE902626A (en)	1985-12-10
IT8548210A0 (en)	1985-06-13
DE3520184C2 (en)	1997-03-13
GB8727055D0 (en)	1987-12-23
AT391806B (en)	1990-12-10
IE58834B1 (en)	1993-11-17
IT1200080B (en)	1989-01-05
GR851430B (en)	1985-11-25
FR2565822B1 (en)	1989-02-17
GB2196852A (en)	1988-05-11
HUT40918A (en)	1987-03-30

Publication	Publication Date	Title
GB2153678B (en)	1988-04-13	Pharmaceutical composition
AU580117B2 (en)	1989-01-05	Analgesic compositions
AU591161B2 (en)	1989-11-30	Fly-attractive composition
EP0173990A3 (en)	1987-05-13	External pharmaceutical composition
AU4454389A (en)	1990-03-22	Pharmaceutical composition
GB8413191D0 (en)	1984-06-27	Pharmaceutical composition
GB2165451B (en)	1988-07-06	Pharmaceutical compositions
GB8410290D0 (en)	1984-05-31	Pharmaceutical compositions
GB8410289D0 (en)	1984-05-31	Pharmaceutical compositions
GB2153677B (en)	1988-04-13	Pharmaceutical composition
GB8513641D0 (en)	1985-07-03	Pharmaceutical composition
GB8409961D0 (en)	1984-05-31	Pharmaceutical compositions
AU584547B2 (en)	1989-05-25	Pharmaceutical `` -aminoalkyl- `` -alkylphenylacetonitriles
AU587505B2 (en)	1989-08-17	Pharmaceutical compositions
GB2153676B (en)	1988-04-07	Pharmaceutical composition
GB8518565D0 (en)	1985-08-29	Pharmaceutical composition
AU578657B2 (en)	1988-11-03	Pharmaceutical compositions
AU7819887A (en)	1988-03-17	Pharmaceutical composition
GB8513640D0 (en)	1985-07-03	Pharmaceutical composition
GB8424167D0 (en)	1984-10-31	Pharmaceutical composition
IE841175L (en)	1984-11-13	Pharmaceutical composition
GB8424513D0 (en)	1984-11-07	Pharmaceutical composition
GB8424514D0 (en)	1984-11-07	Pharmaceutical composition
GB8426767D0 (en)	1984-11-28	Pharmaceutical composition
GB8429710D0 (en)	1985-01-03	Pharmaceutical composition